|Bid||122.70 x 100|
|Ask||122.82 x 200|
|Day's Range||122.12 - 123.50|
|52 Week Range||87.49 - 130.29|
|PE Ratio (TTM)||91.82|
|Earnings Date||Apr 25, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||114.75|
Wright Medical (WMGI) is focusing on product innovation through research and development. Also, the company is focusing on strategic acquisition and divestitures.
PALO ALTO, Calif. , March 20, 2018 /PRNewswire/ -- Varian (NYSE: VAR) announced PTC St. Petersburg Center of Nuclear Medicine of the Sergey Berezin Medical Institute successfully completed its first pediatric ...
The acquisition of Sirtex will fortify Varian Medical's (VAR) footprint in Australia. The transaction is likely to close in late May 2018.
PALO ALTO, Calif. , March 14, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has received clearances from the U.S. antitrust authorities and the German Federal Cartel Office (FCO) on the proposed ...
PALO ALTO, Calif. , March 12, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced that it will report results for the second quarter of fiscal year 2018 after market close on Wednesday, April 25, 2018 ...
PALO ALTO, Calif. , March 9, 2018 /PRNewswire/ -- Varian (NYSE: VAR) has been selected by the Instituto Mexicano del Seguro Social (IMSS) to equip seven treatment centers across Mexico with modern radiotherapy ...
Glancy Prongay & Murray LLP announces an investigation on behalf of Varian Medical Systems, Inc. investors concerning the Company and its directors’ and officers’ possible violations of state laws.
Varian Medical (VAR) has a strong international presence and growing proton therapy market. However, intense competition adds to woes.
BALTIMORE, Md., March 5, 2018 /PRNewswire/ -- Varian (VAR) and the University of Maryland School of Medicine (UMSOM) announced today they have reached their first educational milestone at the Maryland Proton Treatment Center (MPTC): more than 150 medical professionals have now completed training to deliver proton therapy – an advanced form of cancer treatment. "Since well before we treated our first patients at MPTC, we have worked with Varian to create a diverse range of educational offerings targeted at physicians, physicists, dosimetrists, radiation therapists, and administrators from across the country and around the world," said Charles B. Simone, II, MD, medical director of MPTC and an associate professor of radiation oncology at UMSOM.
PALO ALTO, Calif. , March 1, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced that Gary Bischoping , chief financial officer, and J. Michael Bruff , senior vice president of investor relations, ...
Zacks Industry Outlook Highlights: Abbott, Becton and Dickinson, Stryker, Varian Medical and Boston Scientific
PALO ALTO, Calif. , Feb. 26, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced it will be demonstrating its portfolio of software solutions for smarter cancer care, March 5-8 in Las Vegas, NV at ...
Varian Medical Systems (VAR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Varian Medical Systems (VAR) acquires Evinance to improve cancer care through CDS software. The company also expects to gain from flagship ARIA's recent certification.
ARIA for medical and radiation oncology receives certification PALO ALTO, Calif. , Feb. 22, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced its ARIA ® oncology information system has achieved Office ...
Expands 360 Oncology care management platform with clinical decision support PALO ALTO, Calif. , Feb. 22, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has acquired privately-held Montreal ...